ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
CG Oncology
CG Oncology is seeking a Senior Manager in Analytical Development to lead the development, validation, and optimization of analytical methods for live viral drug products. The role involves guiding analytical strategy, working with contract labs, and ensuring regulatory compliance, with a focus on late-stage and commercial biologics. The position offers significant influence over product licensure and the opportunity to impact patient outcomes in oncology.
CG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CG Oncology.
43% above the average for this role